Table 3.
Categories of potential clinical consequences of errors in the medication process
| Nonsignificant n (%) | Significant n (%) | Serious n (%) | Fatal n (%) | Interrater variation | |
|---|---|---|---|---|---|
| Prescribing, CPOE | 0 | 4 (40) | 4 (40) | 2 (20) | κ = 1,0a |
| Dispensing, observational study, n (%) | 0 | 6 (66) | 3 (33) | 0 | κ = 0.82a |
| Dispensing, unannounced visit, n (%) | 4 (44) | 5 (56) | 0 | 0 | κ = 0.75a |
| Administration, n (%) | 29 (20) | 38 (27) | 73 (51) | 2 (1) | κ = 0.54a |
Notes:
a
Kappa test for interrater agreement; the highlighted areas represent errors with the potential to harm patients.
Abbreviation: CPOE, computerized physician order entry.